ConductScience.org, home

Paper2467397

Abnormal haemostasis in small cell lung cancer.

Milroy R and 5 others. Thorax, 1988. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Abnormal haemostasis in small cell lung cancer. Papers, record 2467397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2467397

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Abnormal haemostasis in small cell lung cancer.
PubMed
Journal
Thorax
PubMed
Year
1988
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2019-05-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Milroy RR
2Douglas JTJ T
3Campbell JJ
4Carter RR
5Lowe GDG D
6Banham SWS W

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Small CellMajor topic
HemostasisMajor topic
Lung NeoplasmsMajor topic
Antineoplastic Combined Chemotherapy Protocols
Blood Platelets
Fibrinolysis
Fibrinopeptide A
Humans
P-Selectin
Platelet Membrane Glycoproteins
beta-Thromboglobulin

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16038391Coagulation disorders in cancer. I. Clinical and laboratory studies.Cancer1967https://conductscience.org/library/papers/6038391PubMed
26322957Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75.Cancer1984https://conductscience.org/library/papers/6322957PubMed
34577065Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia.Br J Haematol1973https://conductscience.org/library/papers/4577065PubMed
44718672A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases.Cancer Res1973https://conductscience.org/library/papers/4718672PubMed
54127138Blood coagulation and fibrinolysis in patients with carcinoma of the lung.J Med1973https://conductscience.org/library/papers/4127138PubMed
64801854Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.Int J Cancer1973https://conductscience.org/library/papers/4801854PubMed
74598771Oral anticoagulant therapy of human cancer.J Med1974https://conductscience.org/library/papers/4598771PubMed
84607877Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis.Hum Pathol1974https://conductscience.org/library/papers/4607877PubMed
9171794Disseminated intravascular coagulation: experience in a major cancer center.Thromb Diath Haemorrh1975https://conductscience.org/library/papers/171794PubMed
101203841Heparin and chemotherapy in the management of inoperable lung carcinoma.Cancer1975https://conductscience.org/library/papers/1203841PubMed
11991145Trial of heparin and cyclophosphamide (NSC-26271) in the treatment of lung cancer.Cancer Treat Rep1976https://conductscience.org/library/papers/991145PubMed
12834136Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.Medicine (Baltimore)1977https://conductscience.org/library/papers/834136PubMed
13268396Platelet-cancer cell interaction in metastasis formation: a possible therapeutic approcach to metastasis prophylaxis.J Med1977https://conductscience.org/library/papers/268396PubMed
14589603Heparin and polychemotherapy for treatment of lung cancer.Cancer Treat Rep1977https://conductscience.org/library/papers/589603PubMed
15638954Fibrinogen kinetics in patients with neoplastic disease.Cancer1978https://conductscience.org/library/papers/638954PubMed
16420161Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies.Am J Clin Pathol1979https://conductscience.org/library/papers/420161PubMed
17375459Anticoagulants in the treatment of small cell carcinoma of the bronchus.Thorax1979https://conductscience.org/library/papers/375459PubMed
18383261Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer.Cancer1979https://conductscience.org/library/papers/383261PubMed
196990959Malignancy and haemostasis.Br J Haematol1980https://conductscience.org/library/papers/6990959PubMed
207391657Significance of plasma fibrinopeptide A (fpA) in patients with malignancy.J Lab Clin Med1980https://conductscience.org/library/papers/7391657PubMed

See all 30 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42469693A new prognostic perspective on preoperative coagulation parameters for lung adenocarcinoma patients: development and validation of the DFP score.BMC Cancer2026https://conductscience.org/library/papers/42469693PubMed
31393394The relationship of plasma fibrinogen with clinicopathological stages and tumor markers in patients with non-small cell lung cancer.Medicine (Baltimore)2019https://conductscience.org/library/papers/31393394PubMed
31164623MALDI Mass Spectrometry Imaging Linked with Top-Down Proteomics as a Tool to Study the Non-Small-Cell Lung Cancer Tumor Microenvironment.Methods Protoc2019https://conductscience.org/library/papers/31164623PubMed
27413710Anticoagulation, ferrotoxicity and the future of translational lung cancer research.Transl Lung Cancer Res2016https://conductscience.org/library/papers/27413710PubMed
22852778Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.BMC Cancer2012https://conductscience.org/library/papers/22852778PubMed
10360671Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.Br J Cancer1999https://conductscience.org/library/papers/10360671PubMed
2595629Proceedings of the British Thoracic Society. 12-14 July 1989, University of Southampton. Abstracts.Thorax1989https://conductscience.org/library/papers/2595629PubMed
1651564Digital gangrene in small cell lung cancer: response to aspirin treatment.Thorax1991https://conductscience.org/library/papers/1651564PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
F22147PubTator's text mininghttps://conductscience.org/library/genes/2147NCBI Gene
PLG5340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
PPBP5473PubTator's text mininghttps://conductscience.org/library/genes/5473NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2467397

GET https://conductscience.org/api/papers/v1/2467397/references?page=2